Swedish HealthTech company Kry has raised over $160 million in a new funding round.
Participants in the latest round, a Series D follow-on, include existing stakeholders Teachers’ Venture Growth, Index Ventures, Accel, Creandum, Project A and new investor klaP Capital Partners, per a Tech Funding News report on Thursday (July 21).
“This is all about creating more resilient and sustainable healthcare services for the longer term,” Kry CEO and Co-founder Johannes Schildt said. “We want more patients across Europe to have faster access to high-quality healthcare, and we want healthcare professionals to spend more time with patients to improve and save lives.”
Olivia Steedman of Teachers’ Venture Growth added, “By providing integrated, digital solutions, Kry has reduced the burden on healthcare systems and delivered improved patient journeys. We’re delighted for Johannes and his team as they continue Kry’s growth story and shape an efficient, sustainable future for healthcare in Europe.”
Founded in 2015 by Schildt, Fredrik Jung Abbou, Joachim Hedenius and Josefin Landgård, Kry is one of the largest telehealth software providers in Europe. Its mobile and web apps let users meet a doctor or therapist from their chosen device.
It operates in Sweden, Norway, and Germany. In the U.K. and France, it operates under the brand name Livi.
In 2020 Kry also introduced a SaaS product in the U.K., where it is a key partner helping the National Health Service (NHS) deliver telehealth services to patients. According to the Livi U.K. website, the solution has already helped over 6 million NHS patients in the country access remote appointments.
As PYMNTS has reported, the telehealth sector experienced a boom during the COVID-19 pandemic but shows no signs of declining use as people adjust to and even relish the new normal of remote appointments.
See also: Telehealth Sector Redoubles Focus on Convenient Care, Smarter Virtual Visits
For all PYMNTS EMEA coverage, subscribe to the daily EMEA Newsletter.
We’re always on the lookout for opportunities to partner with innovators and disruptors.
Learn More